2024 ASCO® Annual Meeting Insights Hub

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

Summaries & Highlights
Breast
GU
GI
Lung
Hematologic Oncology
Skin
GYN
Head & Neck
Sarcoma

Playback speed

10 seconds

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcomes - Nivo + Rela vs. Nivo for Previously Untreated Metastatic/Unresectable Melanoma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Hussein Tawbi

397 views

June 12, 2024

Chapters

RELATIVITY-047 Trial Overview & Design

00:00

3-Year Survival & Response Rates

02:56

Safety Profile & Future Directions

08:32

Comments 0

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Skin

ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical Outcomes…

2024 ASCO® Annual Meeting Insights Hub

L. Burton

129 views

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

776 views

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

326 views

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

478 views

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

464 views

ASCO® 2024 Insights: "Safety & Efficacy of First-in-Class CXCR1/2 In…

2024 ASCO® Annual Meeting Insights Hub

S. Patel

60 views

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been a…

2024 ASCO® Annual Meeting Insights Hub

P. Corrie

290 views

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi vs. Adju…

ecancer

C. Blank

47 views

ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Melanom…

2024 ASCO® Annual Meeting Insights Hub

A. Betof Warner

191 views

ASCO® 2024 Insights: "PIVOTAL Study - Neoadjuvant Daromun vs. Immedi…

ecancer

A. Hauschild

37 views

ASCO® 2024 Insights: "QoL Data With Neoadjuvant Ipi & Nivo in Resect…

2024 ASCO® Annual Meeting Insights Hub

J. Lijnsvelt

58 views

ASCO® 2024 Insights: "PIVOTAL Study - Daromun vs. Immediate Surgery …

2024 ASCO® Annual Meeting Insights Hub

A. Hauschild

65 views

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

397 views

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macro…

2024 ASCO® Annual Meeting Insights Hub

C. Blank

264 views

ASCO® 2024 Insights: "SCOPE Trial - Efficacy & Safety of SCIB1 Vacci…

2024 ASCO® Annual Meeting Insights Hub

H. Shaw

21 views

ASCO® 2024 Insights: "Macroscopic Stage III Melanoma and Immunothera…

2024 ASCO® Annual Meeting Insights Hub

H. Kluger

124 views

ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in Systemic T…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

188 views

ASCO® 2024 Summary: "PD-1-Refractory Advanced Melanoma - Getting to …

2024 ASCO® Annual Meeting Insights Hub

M. Mckean

145 views

ASCO® 2024 Insights: "NEO-TIM Trial - Combination or Sequence of Vem…

2024 ASCO® Annual Meeting Insights Hub

P. Ascierto

39 views

ASCO® 2024 Insights: "Roginolisib, an Oral, Highly Selective and All…

2024 ASCO® Annual Meeting Insights Hub

A. Di Giacomo

37 views

ASCO® 2024 Insights: "KEYNOTE-942 Trial - 3-Year Update on mRNA-4157…

2024 ASCO® Annual Meeting Insights Hub

J. Weber

223 views

ASCO® 2024 Insights: "RELATIVITY-048 Trial - Efficacy and Safety of …

2024 ASCO® Annual Meeting Insights Hub

P. Ascierto

202 views

ASCO® 2024 Insights: "RegoMel Trial - Regorafenib in Patients With P…

2024 ASCO® Annual Meeting Insights Hub

I. Dirven

32 views

ASCO® 2024 Insights: "OBX-115, IL2-Sparing Engineered TIL Cell Thera…

2024 ASCO® Annual Meeting Insights Hub

R. Amaria

39 views

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in St…

2024 ASCO® Annual Meeting Insights Hub

A. Hauschild

527 views

ASCO® 2024 Insights: "Individualized Neoantigen Therapy mRNA-4157 (V…

2024 ASCO® Annual Meeting Insights Hub

M. Mckean

31 views

ASCO® 2024 Insights: "Novel RNA-Nanoparticle Vaccine for the Treatme…

2024 ASCO® Annual Meeting Insights Hub

B. Doonan

40 views